Annual Report

Overview

The report describes a year of significant pipeline progress, including advancement of the obesity portfolio, regulatory submissions for rare-disease assets and completed pre-clinical work for inflammation programs. The company also advanced a double materiality assessment to refine its ESG strategy and prepare for CSRD. Employee numbers increased from 196 at the start of 2023 to 253 at year-end.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2023
Period: 1 January 2023 – 31 December 2023
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services